Biologic and Biochemical Activities of Continuous Macrophage Cell Lines P388D1 and J774.1
Ralph Snyderman(Duke University), Hillel S. Koren(Durham County Department of Public Health), Dina G. Fischer(Duke University), Marilyn C. Pike(Bethesda Hospital)
Cited by 144
Related Papers
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
|Circulation|2002|652
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
|Annals of the Rheumatic Diseases|2013|340
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
|Kidney International|1999|305